Literature DB >> 22094559

Toll-like receptors (TLRs) in innate immune defense against Staphylococcus aureus.

Giampiero Pietrocola1, Carla Renata Arciola, Simonetta Rindi, Antonella Di Poto, Antonino Missineo, Lucio Montanaro, Pietro Speziale.   

Abstract

Toll-like receptors (TLRs) are the most important class of innate pattern recognition receptors (PRRs) by which host immune and non-immune cells are able to recognize pathogen-associated molecular patterns (PAMPs). Most mammalian species have 10 to 15 types of TLRs. TLRs are believed to function as homo- or hetero-dimers. TLR2, which plays a crucial role in recognizing PAMPs from Staphylococcus aureus, forms heterodimers with TLR1 or TLR6 and each dimer has a different ligand specificity. Staphylococcal lipoproteins, Panton-Valentine toxin and Phenol Soluble Modulins have been identified as potent TLR2 ligands. Conversely, the ligand function attributed to peptidoglycan and LTA remains controversial. TLR2 uses a MyD88-dependent signaling pathway that results in NF-kB translocation into the nucleus and activation of the expression of pro-inflammatory cytokine genes. Recognition rouses both an inflammatory response, culminating in the phagocytosis of bacteria, and an adaptive immune response, with the presentation of resulting bacterial compounds to T cells. Here, recent advances on the recognition of S. aureus by TLRs are presented and discussed, as well as the new therapeutic opportunities deriving from this new knowledge.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22094559     DOI: 10.5301/ijao.5000030

Source DB:  PubMed          Journal:  Int J Artif Organs        ISSN: 0391-3988            Impact factor:   1.595


  30 in total

1.  The anti-inflammatory effect of combined complement and CD14 inhibition is preserved during escalating bacterial load.

Authors:  Kjetil H Egge; Andreas Barratt-Due; Stig Nymo; Julie K Lindstad; Anne Pharo; Corinna Lau; Terje Espevik; Ebbe B Thorgersen; Tom E Mollnes
Journal:  Clin Exp Immunol       Date:  2015-07-19       Impact factor: 4.330

2.  Discovery of wall teichoic acid inhibitors as potential anti-MRSA β-lactam combination agents.

Authors:  Hao Wang; Charles J Gill; Sang H Lee; Paul Mann; Paul Zuck; Timothy C Meredith; Nicholas Murgolo; Xinwei She; Susan Kales; Lianzhu Liang; Jenny Liu; Jin Wu; John Santa Maria; Jing Su; Jianping Pan; Judy Hailey; Debra Mcguinness; Christopher M Tan; Amy Flattery; Suzanne Walker; Todd Black; Terry Roemer
Journal:  Chem Biol       Date:  2013-02-21

3.  The Human Pathogen Streptococcus pyogenes Releases Lipoproteins as Lipoprotein-rich Membrane Vesicles.

Authors:  Massimiliano Biagini; Manuela Garibaldi; Susanna Aprea; Alfredo Pezzicoli; Francesco Doro; Marco Becherelli; Anna Rita Taddei; Chiara Tani; Simona Tavarini; Marirosa Mora; Giuseppe Teti; Ugo D'Oro; Sandra Nuti; Marco Soriani; Immaculada Margarit; Rino Rappuoli; Guido Grandi; Nathalie Norais
Journal:  Mol Cell Proteomics       Date:  2015-05-27       Impact factor: 5.911

4.  Pam2CSK4 and Pam3CSK4 induce iNOS expression via TBK1 and MyD88 molecules in mouse macrophage cell line RAW264.7.

Authors:  Panthong Kulsantiwong; Matsayapan Pudla; Chanya Srisaowakarn; Jitrada Boondit; Pongsak Utaisincharoen
Journal:  Inflamm Res       Date:  2017-06-07       Impact factor: 4.575

5.  The immunologically active oligosaccharides isolated from wheatgrass modulate monocytes via Toll-like receptor-2 signaling.

Authors:  Chia-Che Tsai; Chih-Ru Lin; Hsien-Yu Tsai; Chia-Jung Chen; Wen-Tai Li; Hui-Ming Yu; Yi-Yu Ke; Wei-Ying Hsieh; Cheng-Yen Chang; Ying-Ta Wu; Chung-Yi Wu; Shui-Tein Chen; Chi-Huey Wong
Journal:  J Biol Chem       Date:  2013-04-29       Impact factor: 5.157

6.  Design and development of stable, water-soluble, human Toll-like receptor 2 specific monoacyl lipopeptides as candidate vaccine adjuvants.

Authors:  Deepak B Salunke; Seth W Connelly; Nikunj M Shukla; Alec R Hermanson; Lauren M Fox; Sunil A David
Journal:  J Med Chem       Date:  2013-07-10       Impact factor: 7.446

7.  In Vivo Role of TLR2 and MyD88 Signaling in Eliciting Innate Immune Responses in Staphylococcal Endophthalmitis.

Authors:  Deepa Talreja; Pawan Kumar Singh; Ashok Kumar
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-02-12       Impact factor: 4.799

Review 8.  The effects of Staphylococcus aureus leukotoxins on the host: cell lysis and beyond.

Authors:  Pauline Yoong; Victor J Torres
Journal:  Curr Opin Microbiol       Date:  2013-02       Impact factor: 7.934

9.  Activation of Human Vδ2+ γδ T Cells by Staphylococcus aureus Promotes Enhanced Anti-Staphylococcal Adaptive Immunity.

Authors:  Andrew J R Cooper; Stephen J Lalor; Rachel M McLoughlin
Journal:  J Immunol       Date:  2020-07-10       Impact factor: 5.422

Review 10.  Innate Immunity to Staphylococcus aureus: Evolving Paradigms in Soft Tissue and Invasive Infections.

Authors:  Stephanie L Brandt; Nicole E Putnam; James E Cassat; C Henrique Serezani
Journal:  J Immunol       Date:  2018-06-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.